HLS Therapeutics Inc. announced that Mr. Ryan C. Lennox has been named General Counsel. Reporting to the CEO, the General Counsel role will focus on supporting and enhancing the company's acquisition efforts, corporate governance directives and general legal requirements. Since 2012, Mr. Lennox has been Director & Senior Counsel at Amgen Inc., responsible for all the legal affairs of Amgen's Canadian affiliate. In more recent years, he had taken on increasing responsibility at Amgen, including managing the legal team and affairs of Amgen's Intercontinental Region, comprised of Canada, Latin America, Turkey, Middle East and Africa. Mr. Lennox is called to the bar in both California and Ontario. Prior to joining Amgen, Mr. Lennox practiced corporate law at McDermott Will & Emery in San Diego, California and Stikeman Elliott in Toronto, Ontario, two international law firms where he advised a wide variety of clients on corporate finance, M&A, private equity, venture capital and other types of transactions.